经皮耳迷走神经刺激对心衰合并失眠者外周自主神经功能的影响及机制

注册号:

Registration number:

ChiCTR2200059439 

最近更新日期:

Date of Last Refreshed on:

2023-02-08 20:59:44 

注册时间:

Date of Registration:

2022-04-29 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

经皮耳迷走神经刺激对心衰合并失眠者外周自主神经功能的影响及机制

Public title:

Effect and mechanism of percutaneous auricular vagus nerve stimulation on peripheral autonomic nerve function in patients with heart failure and insomnia

注册题目简写:

English Acronym:

研究课题的正式科学名称:

经皮耳迷走神经刺激对心衰合并失眠者外周自主神经功能的影响及机制

Scientific title:

Effect and mechanism of percutaneous auricular vagus nerve stimulation on peripheral autonomic nerve function in patients with heart failure and insomnia

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

黄清清 

研究负责人:

艾思志 

Applicant:

Qingqing Huang 

Study leader:

Sizhi Ai 

申请注册联系人电话:

Applicant telephone:

+86 13525991174

研究负责人电话:

Study leader's
telephone:

+86 18625960670

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1609752449@qq.com

研究负责人电子邮件:

Study leader's E-mail:

ai5542591@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

河南省新乡市卫辉市健康路88号

研究负责人通讯地址:

河南省新乡市卫辉市健康路88号

Applicant address:

88 Jiankang Road, Weihui, Xinxiang, Henan

Study leader's address:

88 Jiankang Road, Weihui, Xinxiang, Henan

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

新乡医学院第一附属医院

Applicant's institution:

The First Affiliated Hospital of Xinxiang Medical College

研究负责人所在单位:

新乡医学院第一附属医院

Affiliation of the Leader:

The First Affiliated Hospital of Xinxiang Medical College

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2021010

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

新乡医学院第一附属医院伦理委员会

Name of the ethic committee:

Ethics Committee of the First Affiliated Hospital of Xinxiang Medical College

伦理委员会批准日期:

Date of approved by ethic committee:

2022-04-01 00:00:00

伦理委员会联系人:

韩文吉

Contact Name of the ethic committee:

Wenji Han

伦理委员会联系地址:

河南省新乡市卫辉市健康路88号

Contact Address of the ethic committee:

88 Jiankang Road, Weihui, Xinxiang, Henan

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

新乡医学院第一附属医院

Primary sponsor:

The First Affiliated Hospital of Xinxiang Medical College

研究实施负责(组长)单位地址:

河南省新乡市卫辉市健康路88号

Primary sponsor's address:

88 Jiankang Road, Weihui, Xinxiang, Henan

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

河南

市(区县):

新乡

Country:

China

Province:

Henan

City:

Xinxiang

单位(医院):

新乡医学院第一附属医院

具体地址:

卫辉市健康路88号

Institution
hospital:

The First Affiliated Hospital of Xinxiang Medical College

Address:

88 Jiankang Road, Weihui

经费或物资来源:

国家科技部研发计划

Source(s) of funding:

National Ministry of Science and Technology R&D Program

研究疾病:

心衰合并失眠  

Target disease:

Heart failure with insomnia

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

I期临床试验 

Study phase:

1

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

1. 构建自主神经功能活动监测系统、并开发基于脑电、心电等信号反馈的迷走神经刺激机制; 2. 探索经皮耳迷走神经刺激对心衰合并失眠者外周自主神经功能的影响及机制。  

Objectives of Study:

1. Build an autonomic nervous function activity monitoring system, and develop a vagus nerve stimulation mechanism based on EEG, ECG and other signal feedback; 2. To explore the effect and mechanism of percutaneous auricular vagus nerve stimulation on peripheral autonomic nerve function in patients with heart failure and insomnia.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1. 急性心衰;
2. 慢性心衰伴急性血流动力学紊乱或急性失代偿患者;
3. 诊断为抑郁及其他精神疾病的患者;
4. 排除其他睡眠相关疾病(OSA等)。

Exclusion criteria:

1. Acute heart failure;
2. Patients with chronic heart failure accompanied by acute hemodynamic disorder or acute decompensation;
3. Patients diagnosed with depression and other mental diseases;
4. Exclude other sleep-related diseases (OSA, etc.).

研究实施时间:

Study execute time:

From 2022-05-01 00:00:00 To 2025-06-21 00:00:00  

征募观察对象时间:

Recruiting time:

From 2022-04-21 00:00:00 To 2025-06-21 00:00:00

干预措施:

Interventions:

组别:

1组

样本量:

50

Group:

Group 1

Sample size:

干预措施:

经皮耳迷走神经真刺激

干预措施代码:

Intervention:

percutaneous ear vagus nerve stimulation

Intervention code:

组别:

2组

样本量:

50

Group:

Group 2

Sample size:

干预措施:

经皮耳迷走神经假刺激

干预措施代码:

Intervention:

percutaneous ear vagus nerve sham stimulation group

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

河南 

市(区县):

 

Country:

China

Province:

Henan

City:

单位(医院):

新乡医学院第一附属医院 

单位级别:

三甲 

Institution
hospital:

The First Affiliated Hospital of Xinxiang Medical College

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

多导睡眠监测

指标类型:

主要指标

Outcome:

Polysomnia monitoring

Type:

Primary indicator

测量时间点:

晚上

测量方法:

Measure time point of outcome:

night

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 45 years
最大 Max age 80 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

临床随机对照试验,单盲

Randomization Procedure (please state who generates the random number sequence and by what method):

Clinical randomized controlled trial, single-blind

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

2027年11月

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

November 2027

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表,PSG

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form, PSG

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2022-04-29 07:56:43